It has been over 30 yr since Traub first reported that lymphocytic choriomeningitis (LCM) virus could cause a life-long, symptomless infection in mice (1-5). The chronic LCM infection or carrier state develops in mice naturally infected in utero (6) or inoculated with LCM virus shortly after birth (7-9). In such carrier mice, high titers of virus in blood and organs continue through life in the absence of detectable circulating antibody. These facts led Burnet and Feuner to postulate that the congenital LCM infection induced immunologic tolerance to the virus (10). Recently, evidence has been presented to challenge this traditional concept of immunologic tolerance in the LCM carrier state. Oldstone and Dixon reported that anti-LCM antibody, while not detectable in the circulation, could be found in kidneys of LCM carriers along with LCM virus and complement (11). Controversy has also arisen over whether persistent LCM viral infection is accompanied by disease. Hotchin has described the occurrence of a late life or slow virus disease (12-14) in chronically infected mice while Minas (15) and Volkert (16), working independently, have not observed any such abnormalities. This paper reports studies on chronic LCM infections in several murine strains. LCM carriers of some strains develop an associated chronic disease consisting of glomerulonephritis, focal hepatic necrosis, extensive lymphoid proliferation, and interstitial round cell infiltrations in many of the body's tissues. The development of disease is related to the amount of LCM virus carried, the size of the anti-LCM antibody response made and the interaction between virus and antibody. Those strains carrying the largest m o u n t of LCM virus and anti-LCM antibody develop the earliest and most severe disease. * This is publication No. 304 from
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Techniques for complement fixation and neutralizing tests for anti-LCM antibody in serum of LCM carrier mice have been previously reported (11) .
In order to determine how much of the T-globulin duted from the kidneys was anti-LCM antibody, the "y-globulin in the eluates was quantitated before and after absorption with normal and LCM infected tissue cultures. Rhesus monkey kidney cultures were grown to a confluent monolayer and then infected with LCM virus. On the 7th day after infection with LCM virus, about 80% of cells contained LCM antigen by direct immunofluorescent technique and these cultures were used for absorptions. 10 nag of protein by weight, eluted from a kidney pool of 2-3 months old SWR/J LCNI carrier mice, was diluted in 2 ml of medium 199, passed through a 0.2/x Millipore filter, and layered over LCM infected monkey kidney cell monolayer contained in a 20 cm 2 bottle. The renal eluate was incubated sequentially in three LCM infected monkey kidney cell culture bottles for a period of 24 hr per bottle. Controls consisted of LCM carrier renal eluates similarly absorbed on noninfected monkey kidney cultures. At the end of 3 days incubation, the treated eluates were collected from the culture bottle and spun at 700 g in an International centrifuge. The concentration of mouse "y-globulin in the supernatants were quantitated using radial immunodiffusion assay employing high titer rabbit anti-mouse "y-globulin diluted 1:160 in agar (21, 22) .
Tea for Antinuclear and Anti-Glomerular Basement Membrane Antibodies.--Pooled eluates from kidneys of LCM carrier mice in a concentration of 130/~g of mouse ~/-globuhn/ml were layered on acetone fixed normal mouse kidney sections for 30-rain. Following two 10 rain phosphate buffer saline washes, the sections were stained with rabbit anti-mouse q-globulin conjugated with fluorescein isothiocyanate (FITC).
Eliraination of Third Component of Guinea Pig Complement (Ct3) in LCM Carrier and
Control M/ce.--Purified guinea pig C'3 obtained through the courtesy of Dr. Manfred Mayer and Dr. Hyin Shin of Johns Hopkins was labeled with ~5I (23) . After labeling, 80-85% of the C'3 was found to be unchanged in the electrophoretically faster, unconverted form when analyzed by immunoelectrophoresis under conditions described by Liuscott and Cochrane (24) . The labeled Ct3 was found to be active in a hemolytic titration, with EAC'la,4,2a, performed by Dr. Nell Cooper.
Approximately ~ /~c of C~3325I was inoculated intravenously into five SWR/J LCM carrier and five control mice. Experiments were run in duplicate. Whole body counts were determined in a well type NaI crystal scintillation counter within 5 rain after injection of C'3-1~5I and repeated at intervals of 2-4 hr. The counts were corrected for coincidence and background. Previous experiments revealed that there was no difference in the elimination of labeled bovine serum albumin or rabbit q~-globulin between SWR/J LCM carriers and controls.
Fixation of Injected Guinea Pig Ct3 in Glomeruli of SWR/J and BIOD2 Old LCM Carrier
M/ce.--Fresh guinea pig serum was injected intravenously into five SWR/J and five B10D2 old LCM carrier and five control mice of each strain. Similarly, zymosan-treated guinea pig serum (24) was injected intravenously into five SWR/J and B 10D2 old carrier mice. 6 hr after injection, all animals were sacrificed. Frozen kidney sections were studied by direct immunoflorescent technique for the presence of guinea pig C~3.
Daerminatdon of LCM--'y-Globulin Complexes in the Circulation of LCM Carrier Mice.--
Pooled fresh sera from 2-3 month old LCM carrier mice were treated with either monospecific rabbit anti mouse q-globulin or rabbit anti-mouse albumin. Three volumes of high titer hyperimmune antiserum were added to each volume of LCM carrier sera. The mixture was incubated at 37°C for 20 rain and then left at 4°C for 4 hr. The resulting precipitate was removed by centrifugation, 700 g X 20 rain. These steps were repeated until addition of specific antiserum caused no visible precipitate and the superantant was free of detectable mouse -),-globulin or albumin by immunoelectrophoresis and Ouchterlony techniques. The amount of infectious virus remaining was assayed by inoculating 10-fold dilutions of the final supernatant intracerebrally into adult SW mice. SIX mice were used per dilution and the I~50 was calculated by method of Reed and Muench (19) . Sera from LCM carrier mice of SWR/J, BIOD2, and AJAX strains were studied by this method. Also, as a control, stock LCM virus was mixed with normal mouse v-globulin and studied similarly.
lmmunofluorescent-Histopathologic Techniques
Fluorescent Antibody Studies.--Tissue blocks were snap-frozen in liquid nitrogen and sections 4/~ thick were cut, fixed, and examined by the direct immunofluorescent technique as previously reported (18, 25) . Rabbit anti-mouse ~toglobulin, anti-mouse albumin, anti-mouse C'3, anti-guinea pig C'3, anti-rat fibrinogen, and guinea pig anti-LCM monospecific antisera were used. Rabbits and guinea pigs were immunized with 0.5 to 1 mg of antigen in complete Freund's adjuvant four to six times over a 4 month period. Details as to preparation of the antigens used and conjugation of qt2-globulins from above antisera to FITC have been reported (25, 26) .
In addition, fluoresceinated guinea pig anti-LCM kindly supplied by Dr. R. Wilsnack of the Baltimore Biological Laboratories, Research Department, Baltimore, Md., was employed.
Histology.--Formalin-fixed paraffin sections of tissue were stained by hematoxylin and eosin and periodic acid-Schitt (PAS) methods.
Pathologiv Changes Associaled with LCM Carrier State
LCM carrier and control mice of the various strains under study were examined for clinical and pathologic changes of an associated disease from 10 days to 24 months of age. Clinical study consisted of daily observations and monthly weights and urinary protein determinations. Weight was recorded to the nearest 0.1 g. Proteinuria was determined by the sulfosalicylic acid method (27) on 24 hr collections. Proteinuria over 5 rag/24 hr was considered abnormal. Histopathologic evidence of chronic disease in LCM carriers included glomerulonephritis, focal hepatic necrosis, generalized lymphoid hyperplasia, and focal lymphoid infiltrations. (Table I ). The SWR/J carriers had the highest concentration of infectious LCM virus, approximately 3 logs more than the CffI or AKR strains which had the least.
RESULTS

LCM
Immunofluorescent Study of Neonatally Infected LCM Carrier Mice.-
Tissues from 10 male and 10 female 2-3 month old LCM carrier and control mice of SWR/J, B10D2, AJAX, AKR, NZB, NZB/W, and CffI strains were studied for distribution of LCM antigen, host "},-globulin, C'3, albumin, and fibrinogen by direct immunofluorescent technique (Table I ). In addition, similar studies were performed on fewer LCM carrier and control mice sacrificed monthly from 10 days to 12 months of age and every 3rd month thereafter. The LCM antigen was found in the cell cytoplasm in all tissues studied and appeared as fine to coarse particles which fluoresced apple green after staining with fluorescein-labeled anti-LCM antibody. The greatest concentration of LCM antigen occurred in brain, liver, and kidney. In contrast to the widespread distribution of viral antigen, there were only two sites of accumulation of plasma proteins: the glomeruli which contained "/-globulin and C'3 and the regions of focal hepatic necrosis which contained all plasma proteins looked for.
Brain: Viral antigen was found irregularly distributed in neurons of the cortex, thalamus, hippocampus, and cerebellum. Uncommonly, cells of the choroid plexus and arterial endothelium contained LCM antigen. No evidence of "y-globulin, C'3, fibrinogen, or albumin deposits was found in CNS.
Liver: In general, the LCM antigen occurred in clumps of otherwise normalappearing parenchymai cells. These cell clumps were scattered and not confined to any specific architectural area of liver lobule. Infrequently, LCM antigen was seen in Kupffer cells, arterial endothelium, or biliary duct epithelium.
The loci of hepatic necrosis, one of the characteristic lesions of this disease, invariably contained LCM antigen, "r-globulin, C'3, fibrinogen, and albumin.
Kidney: Viral antigen was observed in the convoluted tubules, connective tissue, arterial endothelium, and glomeruli. The distribution of LCM antigen in the glomeruli was heaviest in the mesangial areas but also occurred in the peripheral wails of capillaries. In addition, both "r-globulin and C'3 were deposited in the glomeruli along the basement membranes of capillaries and in Reciprocal of log dilution giving a 50°~ lethal end point per 0.03 ml intracerebral inoculure. Number is the mean value of the I.Ds0 end points obtained with organs from four individual mice.
§ Degree of involvement as determined by direct immunofluorescence: 0, negative result; -t-, less than 2% cells involved; +, 2-10% cells involved; +% greater than 10% cells involved.
[[ Degree of giomerulsr involvement as determined by direct immunofluorescence: 0, no globulin deposit; q-, minimal globulin deposit in general limited to mesangial area; +, moderate globulin deposit in mesangial and peripheral loop area; ++, marked globulin deposits in mesangial and peripheral loop areas. Neither ~/-globulin nor C'3 was found deposited in any other tissues studied except in areas of focal necrosis in the liver. the mesangia (Fig. 2 ). There was no corresponding mouse albumin or fibrinogen deposition. A marked difference among various strains of LCM carrier mice as to amount of glomerular-bound "r-globulin was noted, with most present in SWR/j and least in CsH and AKR LCM carriers (Fig. 3) . This was of interest since 3 month old SWR/J LCM carriers had been shown to contain about 3 logs more infectious virus than 3 month old CsH LCM carriers (Table I) . Control mice inoculated with isologous normal brain at birth had neither significant "r-globulin nor C'3 deposits in their glomeruli.
3. Nature of the "r-Globulin Deposits in the Renal Glomeruli.--The "r-globulin (20) . 1.2 C'Hs0 units were used in the assay. The antigen was specific LCM complement-fixing antigen. Any reading below 0.41 indicates 25% or more comolement fixation and is considered significant. eluted from the glomeruli, when assayed in a microcomplement fixation test in the presence of added specific LCM antigen, was shown to contain antibody to LCM virus (11) . Experiments were designed to determine whether the mount of anti-LCM antibody deposited in the kidneys of LCM carrier mice increased with time and whether the difference in kidney bound 7-globulin seen in C~-I and SWR/J LCM carriers was related to the difference in amount of anti-LCM antibody in the deposits. strains increased as the mice aged. In addition, more anti-LCM antibody was found in the kidneys of SWR/J than in CffI LCM carrier mice at both 3 and 6 months of age. Neither anti-glomerular basement membrane antibody nor antinuclear antibody was detected in the renal eluates of LCM carrier mice.
The concentration of mouse'r-globulin present in the renal eluate of 2 month old SWR/J carriers was found to be approximately 250 ~g/ml or about 4-5 % of the total protein eluted. Addition of the renal eluate to LCM infected monkey kidney ceils resulted in the absorption of 130/~g or approximately ~ of the eluted ~/-globulin (Table III) . No significant absorption of "r-globulin was noted when the renal eluate was incubated with noninfected monkey kidney cells. neonatally infected SWR/J carriers was studied for the presence of mouse "yglobulin by direct immunofluorescent technique. Faint mesangial deposition of "y-globulin was found in the glomeruli of only one 10 day old SWR/J carrier, while a significant deposition of T-globulin in both mesangia and peripheral capillary walls was found in the glomeruli of 14 of 15 21-day-old SWR/J LCM carriers.
Time of Appearance of Glomerular
Elimination of Guinea Pig C~3 in LCM Carrier and Control SWR/J Mice.--
Elimination of the C'3-125I label from SWR/J carrier and control mice is illustrated in Fig. 1 . The rapid elimination in the first 5 hr in both groups is probably, in part, due to the rapid removal of the inactive contaminant (C'3i-125I). From the 5th to 15th hr, the rate of elimination of label from LCM carriers was rapid with a half-life of 4 hr compared to 12 hr for controls.
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Fxo. I. Elimination of guinea pig C'3 in SWR/J LCM carrier and control mice. The A part of the curve represents the rapid elimination of the labeled inactive contaminant (C~3i I*) and the half-life is 2~-2~ hr in both LCM carriers and control mice. The B portion of the curve represents the rate of elimination of active C'3 I* in which the half-life of label in LCM carriers is 4 hr compared to 12 hr in controls. Each point on the graph represents the average value for five mice.
Fixation of Guinea Pig C'3 in the Glomeruli of LCM Carrier M/ce--By direct
immunofluorescent technique, guinea pig C'3 was detected in both mesangia and capillary walls of the glomeruli of LCM carrier mice of SWR/J and B10D2 old strains 6 hr after the intravenous injection of fresh guinea pig serum. After the injection of fresh guinea pig serum into control mice, or zymosan-treated guinea pig serum into SWR/J or B10D2 old LCM carriers, guinea pig Cr3 was not detectable in peripheral capillary walls of glomeruli.
7. Circulating Antigen-Antibody Complexes in 2-3 Month Old LCM Carrier Mice.--Finding of LCM antigen, anti-LCM antibody, and complement in the glomemU of LCM carrier mice suggested that these deposits represented trapped circulating virus-antibody complexes. If circulating virus--"/-globulin complexes were present, the removal of host "/-globulin should result in a lowering of the LD~0 end point when the treated sera were titered in susceptible mice. LCM cartier sera lost approximately 3 logs of infectivity after removal of 3'-globulin with rabbit anti-mouse "/-globulin, while no loss followed similar treatment with anti-mouse albumin (Table IV) . Mixtures of stock LCM virus and normal mouse "/-globulin did not result in formation of precipitable LCM-7-globulin complexes indicating the immunologic specificity of the complexes found in the sera of cartier mice. 
TABLE IV
Viru.~--~-GlobuUn Complexes in Sera of 2-3 Month Old LCM
Chronic Disease Associated with the LCM Carrier State in Various Murine Strains
In certain murine strains a disease is associated with the LCM cartier state (Table V) . This disease clinically is characterized by increased proteinuria in NZB, SWR/J, NZB/W strains, and an increased early mortality in NZB and NZB/W mice. Except for a terminal loss of weight in the NZB and NZB/W mice, no significant difference in weight was observed between LCM carrier or control mice in any of the strains studied.
Histopathologically, the cardinal manifestations of chronic disease occurred in the kidney and liver. In the kidney, the earliest manifestations of disease were endothelial and mesangial proliferation in capillaries of renal glomeruli. Later, varying gradations of basement membrane thickening, intracapillary hyalinization, and capillary occlusion developed (Fig. 4) . In the liver, scattered areas of focal necrosis with mixed inflammatory infiltrates began to appear as early as
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2 months in SWR/J carriers and were numerous in all strains observed except CffI by 1 yr (Fig. 5) . Location of the focal areas of necrosis had no detectable relationship to hepatic architecture. Appearing with the liver and kidney lesions were excessive lymphoid proliferations and mononuclear interstitial infiltrates, predominantly in liver, kidney, lungs and, to a lesser extent, in pancreas, adrenal, omental fat, heart, spleen, thymus and, rarely, brain (Fig. 6) .
Histologic evidence of disease in kidney and liver occurred as early as 2 months of age in SWR/J but has not been observed over a 24 month period in CffI LCM carriers. The disease is severe in NZB and NZB/W mice. By 5 months of age, 100% of NZB female LCM carriers demonstrated proteinuria over 5 mg/24 hr and by 6 months 20 of 20 female LCM carriers had died, apparently of nephritis. By 9 months, over 90 % of male NZB LCM carrier mice also were dead of nephritis. Preliminary studies with Dr. P. H. Lambert suggest both an earlier appearance and an increase in fiter of antinnclear antibody in the serum of NZB and NZB/W LCM carrier mice compared to NZB or NZB/W controls.
DISCUSSION
Mice infected at birth with LCM virus are capable of making an anti-LCM antibody response throughout most of their lives. This antibody cannot be detected free in the circulation because of an excess of antigen or virus, but the presence of antibody can be inferred from the circulating %globulin-virus corn-plexes. Anti-LCM antibody can be dissociated from antibody-virus complexes deposited in the kidneys and then measured directly. The earlier failure to detect circulating, neutralizing, or complement-fixing anti-LCM antibodies in LCM carders suggested that these mice were immunologically tolerant to the virus to which they had been exposed early in life (7-10, 16, 28) . However, it now is clear that an early exposure to LCM virus does not induce tolerance even if persistent viral infection in the host maintains continuous viral excess in tissues and blood. One might well question whether virus infection under any conditions can induce immunologic tolerance. With the possible exception of some tumor viruses, various in ~tero or early life, experimental or natural exposures to virus, including human in ut~ro infections with rubella and cytomegalovirus, have not resulted in tolerance.
It is not possible to be sure whether or not early infection with LCM or other viruses induces an immunological hyporesponsiveness since an accurate measure of the total antibody in the presence of an excess of viral antigen is impossible. Also, it is difficult to select a standard immunoresponse by which to judge the immunocompetence of the neonatally infected host. However, that the response of the LCM carriers is long lasting, even perhaps life long, is indicated by the increasing accumulation of T-globulin and anti-LCM antibodies in the kidney with age.
The size and time of initial detection of the anti-LCM response in LCM carriers varies among different strains of mice. In the strains carrying the greatest amount of virus, the antibody response appears to be the largest while those strains with the least virus have the smallest amount of antibody. The time of initial detection of the anti-LCM antibody is probably a function of the size of the response and therefore is earliest in those strains making the largest responses. In SWR/J carrier mice, which make the largest anti-LCM response, significant accumulation of 7-glob-lin is present in the glomeruli at 3 wk of age. This observation is only presumptive evidence for anti-LCM antibody but it fits with the detection of circulating 7-globulin-virus complexes and the presence of dissociable C'-fixing anti-LCM antibodies in the kidneys at 8 wk of age. While some of the anti-LCM antibody present in nursing carriers possibly might be derived from the mother's milk, since the mother becomes infected by contact with her offspring and makes a response to the LCM virus, the uninterrupted increase in all measures of anti-LCM antibody in the carriers postweaning strongly suggest that most, if not all, antibody present in the carriers is made by them.
There is considerable difference in the amount of virus present in LCM carriers of different murine strains. While all strains showed a comparable widespread distribution of viral antigen among the various tissues, there was a better than 1000-fold difference between the amount of infectious virus carded by the most susceptible SWR/J strain and the most resistant C~q strain. If ]mmuno-logic tolerance were to be induced by the LCM virus in the carrier state one might expect the strain with the greatest amount of virus to be the most likely to be tolerant. In fact the opposite is the case and, while no strain was found to be tolerant, the strain with the most virus had the most detectable anti-LC1V[ antibody. It is of interest that the amount of virus in the carriers of various strains correlated well with the susceptibility of adults of those strains to lethal effects of inoculation with LCM virus, i.e., the more virus in the carriers of a strain the more suceptible were adults of that strain to infection (17) .
LCM carrier mice of several strains developed a characteristic disease consisting of chronic glomerulonephritis, focal hepatic necrosis, and generalized proliferation of lymphoid tissues with widespread focal interstitial lymphoid infiltrations. In view of the heavy proteinuria and advanced destruction of renal parenchyma, the renal lesion was in all likelihood the fatal component of the disease. The focal hepatic necroses varied in size involving from only a few to nearly 100 liver cells as seen on routine histologic sections but never became large, confluent, or appeared numerous enough to cause death. The hyperplastic and infiltrative changes in the lymphoid tissue were not associated with detectable tissue injury but rather appeared to be a proliferative response to antigenic stimulation.
The severity and time of onset of the disease associated with the LCM carrier state varied greatly from strain to strain. Those strains with the greatest amount of virus and the most antibody developed the earliest and most severe disease while the C~I strain with least virus and antibody had no detectable disease during a 2 yr observation period. The most susceptible strain, the SWR/J, had "y-globulin accumulations in the glomeruli detectable at 3 wk of age and had histologically evident kidney, liver, and lymphoid disease by 2 months of age. In view of this early onset of disease in the more susceptible strains of mice the terms "late life" or "slow viral" disease are not accurate (29, 30) . Since the disease is chronic and progressive regardless of when it begins, we have chosen to refer to it as chronic LCM disease. The finding of chronic LCM disease with varying severity in different strains of mice is in agreement with observations of other workers. Hotchin (12, 14) , who described a similar disease, worked with a Swiss albino herd-bred (NYLAR-A) strain which is probably closely related to the inbred Swiss albino SWR/J strain. Volkert (16) , who did not observe disease in LCM carriers, worked with C3H and AKR strains. Our observations have not been expanded past early life for the AKR strain because of its high incidence of leukemia; however, the relatively low amounts of LCM virus carried by AKR mice suggests that this strain, like C3H, would be resistant to development of disease.
Some aspects of pathogenesis of chronic LCM disease seem reasonably clear while others are not yet understood. On the basis of in vivo observations of the widespread distribution of LCM virus and the apparent lack of associated cellular injury, plus the lack of cytopathogenicity of LCM virus carried in a variety of cultured cells, it seems likely that the LCM virus itself causes little serious injury to cells which it infects. If this is true, the renal and hepatic injury resulting from persistent LCM virus infection must be caused by more than the mere presence of virus. This is similar to the situation in adult mice inoculated with LCM virus in which acute fatal disease did not result from infection alone but occurred only in infected animals capable of an immune response. Immunosuppression prior to infection prevented acute disease (31) (32) (33) (34) (35) . Thus, the interaction of the host immune response with the infecting agent appeared to be the essential pathogenetic event. Just so, in the chronic LCM disease, the interaction of the host's immune response and the LCM virus appears to be involved. If this immunologic reaction is the essential element of chronic LCM disease, then this disease could develop in any animal chronically infected with LCM and need not be restricted to the experimental neonatal infections reported here. An example might be the glomerulonephritis reported by Hirsch et al (36) in young thymectomized and LCM infected mice.
The glomerulonephritis of chronic LCM disease appears to have an immune complex pathogenesis, i.e., circulating virus-antibody complexes are trapped in the glomerular filter along with C ~ and serve as a phlogogenic stimulus-causing disease. That circulating complexes of quite nontoxic antigens and antibody will become trapped in glomeruli and cause glomerulonephritis has been clearly demonstrated in a number of situations (37) (38) (39) . In the LCM carrier, the specificity of the process by which complexes accumulate in the glomeruli is indicated by the fact that 50 % of the "r-globulin eluted from the kidneys reacted with LCM antigen. In view of the conditions of the elution, it is likely that more than 50 % of the ~/-globulin fixed in the kidneys was anti-LCM antibody. Further, the demonstration of: (a) circulating virus-'y-globulin complexes, (b) viral antigen, "y-globulin, and C' deposited along glomerular capillary basement membranes in a granular to lumpy pattem, (c) virus and C'-fixing anti-viral antibody in the kidney, and (d) C' fixation in vivo to the glomerular capillary walls all are in complete agreement with a LCM antigen-antibody complex pathogenesis for this nephritis. Thus, while the virus is an essential component in the pathogenesis, the nephritis does not appear to be virus induced in the sense of a direct cytotoxic action of the virus per se. Rather, the virus acts as a foreign serum protein does in serum sickness or DNA in lupus erythematosus, merely as the antigenic part of an antigen-antibody complex which actually exerts its phlogogenic stimulus by virtue of the structure of the antibody not the antigen.
The pathogeneses of the focal hepatic necrosis and lymphoid reactions are less clear. For the hepatic injury, several immunologic possibilities exist. First, large amounts of circulating antigen-antibody complexes can cause focal hepatic necrosis (40) . In such situations the complexes may be seen lodged in hepatic sinusoids. Whether the hepatic injury in this situation results from compromised blood flow or from the presence of deposits of phlogogenic material or both is not known. Second, the interaction of LCM antigen or LCM induced neoantigen in hepatic cells with circulating antibody might cause injury to the cells. In vitro support for this concept has been obtained by Koprowski using tissue cultures infected with rabies virus (41) and by us using mouse embryo tissue cultures infected with LCM virus. In both cases the virus itself showed no cytopathogenic effect but when specific anti-viral antibody and C' were added to the media death of infected cells occurred. Whether either or both of these two mechanisms operates in chronic LCM disease remains to be established but they are certainly likely possibilities. The nature and significance of the lymphoid hyperplasia and interstitial infiltrations are more obscure but these Mterations appear similar to those sometimes seen in animals hyperimmunized to protein antigens and may merely be the result of long standing antigenic stimulation.
It appears likely that some of the characteristics of chronic LCM infection may be found in other persistent viral infections with high viremias. Preliminary studies in our laboratory have shown deposits of host T-globulin and CI3 in the glomeruli of mice with scrapie, lactic dehydrogenase, and leukemic viral infections, accompanied by glomerulonephritis in the latter two. If the parallel is complete, specific antiviral antibody should be obtainable from the glomeruli of mice with these infections.
SUMMARY
Mice infected shortly after birth with lymphocytic choriomeningitis (LCM) virus are not immunologically tolerant, although they carry the virus throughout life. These LCM carrier mice make anti-LCM antibody, which apparently complexes with viral antigen in the circulation and these complexes accumulate in the glomeruli.
LCM carrier mice of different strains vary significantly as to concentration of detectable infectious virus in their tissue, amount and time of appearance of anti-LCM antibody, and development of an associated chronic disease. The chronic disease consists primarily of glomerulonephritis, focal hepatic necrosis, and disseminated lymphoid infiltrations. LCM carriers of the SWR/J strain contain high tissue concentrations of virus, considerable anti-LCM antibody detectable in the glomeruli by 3 wk to 2 months of age and develop chronic disease within the first 2-3 months of life. In contrast, C~-I strain LCM carriers contain 1/1000 as much infectious virus, less detectable anti-LCM antibody, and have not, over a 24 month observation period, developed any detectable disease. B10D2 old and new carrier mice with intermediate amounts of virus develop chronic disease during the latter half of the first year of life.
The pathogenesis of the glomerulonephritis of chronic LCM disease is ap-parently related to the formation of circulating virus-antibody complexes which are trapped in the glomerular filter. There is no evidence for direct glomerular injury by the virus nor for any autoimmune response by the host. FIO. 5. Light photomicrograph of a hematoxylin and eosin-stained liver section from a 10 month old B10D2 old LCM carrier mouseshowingarea of focal necrosis with infiltrating acute and chronic inflammatory cells. Similar loci were scattered throughout the liver without detectable relationship to hepatic architecture.
Fro. 6. Light photomicrographs of hematoxylin and eosin-stained tissues from a 10 wk old SWR/J LCM carrier mouse. Interstitial predominantly round cell infiltrations are seen in a, kidney, b, liver, c, lung, d, omental fat.
